BioSpace News Archive

BioCapital

Troubling New Report on Hospital Infections Comes While the Centers for Medicare & Medicaid Services Considers Discontinuing Publicly Reporting Rates

One out of 25 hospital patients in the U.S. contracts a healthcare-associated infection (HAI), resulting in billions of wasted dollars and an alarming 90,000 deaths annually.

June 20, 2018
·
4 min read
Policy

STAAR Surgical Announces Resolution of FDA Warning Letter

The lifting of the Warning Letter is the result of a comprehensive remediation program that not only addressed the issues raised by the FDA in the 2014 Warning Letter

June 20, 2018
·
2 min read
Business

Bio-Tissue, Inc. Highlights Publication of DREAM Study

Bio-Tissue, Inc. highlighted the publication of the DRy Eye Amniotic Membrane (DREAM) study in Clinical Ophthalmology.*

June 20, 2018
·
3 min read
Job Trends

Saranas Announces Scheduled Presentations at TVT 2018 in Chicago

Saranas Inc. has been invited to present at the Transcatheter Valve Therapies (TVT) Structural Heart Disease Summit

June 20, 2018
·
2 min read
Psoriasis Treatments to Become Cheaper as Biosimilars Compete in $5 Billion U.S. Psoriasis Drugs Market – New Study by iData Research

A new study by iData Research estimates that there are nearly 150,000 new cases of psoriasis (PsO) every year in the United States, affecting 2.2% of the population.

June 20, 2018
·
2 min read
Pharm Country

Eight Launches AI-Powered Personal Sleep Coach

The Sleep Coach identifies what is wrong with your sleep and presents it in easy to follow insights and recommendations.

June 20, 2018
·
4 min read
Policy

Amneal Announces Patent Litigation Settlement Agreement with Actavis Concerning Rytary®

Amneal Pharmaceuticals, Inc. announced that it has entered into a settlement agreement with Actavis Laboratories FL, Inc. and Actavis Pharma Inc. (collectively, “Actavis”) resolving patent litigation related to Rytary® (carbidopa-levodopa).

June 20, 2018
·
8 min read
Largest mental health bike ride in Canada aims to bring mental illness out of hiding

Ride Don’t Hide supports Canadians to open up and seek help

June 20, 2018
·
3 min read
Policy

Health Canada Approves Taltz (ixekizumab) for Treatment of Active Psoriatic Arthritis

The approval of Taltz is based on the Phase 3 clinical trials that demonstrated efficacy on both joints and skin symptomsi

June 20, 2018
·
8 min read
BioMidwest

Blue Cross and Blue Shield Companies Improve Health in Communities Across the Country

Support continues for community initiatives to solve social determinants of health and combat the opioid epidemic

June 20, 2018
·
4 min read